A new in-depth analysis of the global Anti-Anxiety Drug Market reveals a robust growth trajectory, driven by the escalating worldwide prevalence of mental health disorders and significant advancements in pharmacological treatments. The market, valued at USD 11.25 billion in 2024, is projected to expand to USD 16.63 billion by 2032, demonstrating a healthy Compound Annual Growth Rate (... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/